SlowBull
The Business Brief TUESDAY, 18 AUGUST 2026
← All stories
Markets

Guggenheim initiates Scribe Therapeutics stock with buy rating

1 source ·2 articles ·2h ago Scribe Therapeutics

Covered by 1 outlet

Investing 2

All coverage · 2 articles

Investing.com Canada ·2h ago

Guggenheim initiates Scribe Therapeutics stock with buy rating

Investing.com UK ·2h ago

Guggenheim initiates Scribe Therapeutics stock with buy rating